Abstract
Drug companies, biotechs, and Wall Street investors are putting their money down on efforts to unlock the secrets of human DNA. But when will genomics deliver on its promise of next-generation drugs and treatments?
RELATED WEB SITES:
http://www.ornl.gov/sci/techresources/Human_Genome/home.html
A U.S. government-maintained Web page for news, policy guidelines, and ethics discussions centered on the international Human Genome Project.
http://www3.techstocks.com/~wsapi/investor/stocktalk-10
A private site where small investors chat, often with scant insight, about a wide variety of biotech stocks.
http://www.tradesmart.com/rumor/
The Biotech Rumor Mill, a gossip zone about biotech companies, much of it anonymous. (See the
site review
in Science's Next Wave.)
http://www.recap.com/
Recombinant Capital, a San Francisco consulting group directed by Mark Edwards. With detailed analytical information on biotech companies, their capitalization, and past press releases.
http://www.sec.gov/cgi-bin/srch-edgar
The U.S. Securities and Exchange Commission's search engine for looking up recent disclosures filed by public companies.
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Health Data Pools: Case-Studies and Involved Interests;Health Data Pools Under European Data Protection and Competition Law;2022
2. OUP accepted manuscript;International Data Privacy Law;2019
3. Agricultural Research;The New Palgrave Dictionary of Economics;2018
4. Science and the Sources of Hype;Public Health Genomics;2012
5. Entrepreneurship and the construction of value in biotechnology;Technology and Organization: Essays in Honour of Joan Woodward;2010-01